NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054268

Registered date:01/06/2024

A study of the relationship between plasma concentrations of linezolid and its relationship with the frequency of adverse events and discontinuation factors.

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedinfectious disease
Date of first enrollment2024/06/01
Target sample size30
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeEvaluate the association between plasma concentrations of LZD and incidence of thrombocytopenia and history of dose interruptions and dose interruption factors.
Secondary OutcomeDifferences between the present study in city hospitals and previous reports, mainly in university hospitals, are discussed.

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients allergic to LZD Patients with disseminated intravascular coagulation syndrome

Related Information

Contact

public contact
Name Daiki Yamaguchi
Address 5-161 Maehata-cho, Tajimi-shi, Gifu Japan 507-8522
Telephone 0572-22-5311
E-mail yamaguchi-daiki@tajimi-hospital.jp
Affiliation Gifu Prefectural Tajimi Hospital pharmaceutical department
scientific contact
Name Daiki Yamaguchi
Address 5-161 Maehata-cho, Tajimi-shi, Gifu Japan
Telephone 0572-22-5311
E-mail yamaguchi-daiki@tajimi-hospital.jp
Affiliation Gifu Prefectural Tajimi Hospital pharmaceutical department